Skip to content
OpenCapital
Earnings
Screener
Charts
Portfolio
Pricing
Connect your AI
Get started
Toggle navigation menu
Stocks
Recursion Pharmaceuticals, Inc.
Business Segments
Business Segments
Business Segments
13 metrics
Clinical development
Consumables
D&A
Discovery
Income Tax Expense (Benefit)
Net loss
Operating Income (Loss)
Other income (loss), net
Other segment items
Platform
Revenue from Contract with Customer, Excluding Assessed Tax
Salaries
Total expenditures for additions to long-lived assets